Study Highlights Diagnostic Challenges and High Mortality in Korsakoff Syndrome
A retrospective study of 1,320 Korsakoff syndrome patients in France found that 30.2% died over a median follow-up of 3.1 years. Mortality risk was elevated with malnutrition, alcoholic liver disease, male sex, and age 80–89 years. The researchers emphasized the need for standardized diagnostic criteria to improve early recognition and management of the disorder.
The study drew on electronic health records from Greater Paris University Hospitals, identifying 1,320 patients diagnosed with Korsakoff syndrome between 2017 and 2022. The typical patient was a man in his early sixties, and roughly 44% entered care through emergency departments. Among a well-documented subset of 114 patients, nearly all cases traced to alcohol use disorder, though vascular dementia, eating disorders, brain tumors, and post-surgical malabsorption also appeared as contributing causes.
Diagnostic difficulty stems from the absence of standardized criteria and the disorder's gradual onset, which can delay recognition for months or years. The condition arises from thiamine deficiency and frequently follows untreated Wernicke encephalopathy, an acute neurological emergency that responds to intravenous vitamin B1. The researchers stressed that improved diagnostic frameworks could enable earlier intervention and better outcomes.
This study could sharpen clinical awareness of a frequently overlooked neurocognitive disorder, particularly among older adults and men with alcohol use histories. Because Korsakoff syndrome often goes unrecognized until significant memory impairment has set in, standardized diagnostic criteria may help clinicians identify cases earlier and initiate thiamine treatment before irreversible damage occurs. Families and caregivers of affected patients may also benefit from clearer guidance, though broader screening efforts would require careful resource allocation and clinician training.